ImmunoGen Company Profile (NASDAQ:IMGN)

Analyst Ratings

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.22)
Consensus Price Target: $12.81 (355.96% upside)

Analysts' Ratings History for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Cantor FitzgeraldReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Royal Bank Of CanadaReiterated RatingSector Perform$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Morgan StanleyReiterated RatingUnderweight$9.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Leerink SwannBoost Price TargetMarket Perform$8.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Jefferies GroupReiterated RatingHold$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Oppenheimer Holdings Inc.Reiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Credit Suisse Group AGInitiated CoverageNeutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014JPMorgan Chase & Co.Reiterated RatingHold$13.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for ImmunoGen (NASDAQ:IMGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/29/2016        
4/29/2016Q316($0.31)($0.37)$23.02 million$19.71 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2016Q216($0.36)($0.38)$17.87 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q116($0.35)($0.39)$15.84 million$14.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2015Q415($0.34)($0.35)$15.42 million$12.61 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2015Q315($0.25)($0.25)$20.95 million$11.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015Q215($0.04)$0.16$37.30 million$48.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2014Q115($0.15)($0.26)$21.80 million$13.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014Q414($0.32)($0.83)$9.72 million$5.74 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2014Q314($0.27)($0.44)$13.28 million$6.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q214($0.18)($0.29)$18.16 million$30.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2013Q114($0.23)($0.13)$12.10 million$17.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013Q4 2013($0.30)($0.26)$3.44 million$3.83 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2013Q3 2013($0.15)($0.02)$11.94 million$25.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2013Q2 2013($0.25)($0.29)$6.02 million$2.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/26/2012Q113($0.25)($0.30)$4.10 million$4.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2012($0.30)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2012($0.26)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2012($0.22)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011($0.22)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011($0.24)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ImmunoGen (NASDAQ:IMGN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.38)($0.38)($0.38)
Q2 20163($0.38)($0.36)($0.37)
Q4 20161($0.42)($0.42)($0.42)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ImmunoGen (NASDAQ:IMGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ImmunoGen (NASDAQ:IMGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/1/2016John LambertEVPSell3,889$8.22$31,967.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016Richard J GregoryVPSell2,369$11.10$26,295.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Daniel M. JuniusCEOSell5,416$13.17$71,328.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016John LambertEVPSell3,889$13.20$51,334.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Daniel M. JuniusCEOSell5,416$13.11$71,003.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015John LambertEVPSell3,889$13.11$50,984.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Charles Q MorrisVPSell5,170$14.00$72,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Dean J MitchellDirectorBuy10,000$12.51$125,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Daniel M. JuniusCEOSell5,497$12.00$65,964.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015John LambertEVPSell3,889$11.73$45,617.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Daniel M. JuniusCEOSell5,335$12.01$64,073.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015John LambertEVPSell3,889$9.55$37,139.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015David Brannon JohnstonCFOSell5,000$15.00$75,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Daniel M. JuniusCEOSell5,416$13.15$71,220.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015John LambertEVPSell3,889$13.16$51,179.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Daniel M JuniusCEOSell5,416$14.34$77,665.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015John LambertEVPSell3,888$14.34$55,753.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Nicole OnettoDirectorSell3,211$13.86$44,504.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015John LambertEVPSell15,000$11.78$176,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Daniel M JuniusCEOSell1,215$8.02$9,744.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015John LambertEVPSell10,000$8.32$83,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Charles Q MorrisVPSell5,240$10.40$54,496.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Daniel JuniusCEOSell15,000$16.40$246,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2014Charles MorrisVPSell6,936$17.35$120,339.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Charles MorrisVPSell13,672$17.10$233,791.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Daniel JuniusCEOSell15,000$16.26$243,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014John LambertEVPSell4,375$14.90$65,187.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Charles MorrisVPSell7,138$17.00$121,346.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Theresa WingroveVPSell6,250$15.04$94,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014John LambertEVPSell4,375$14.53$63,568.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2013Daniel JuniusCEOSell15,000$15.11$226,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013John LambertEVPSell4,375$14.70$64,312.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Charles MorrisVPSell12,500$13.75$171,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2013John LambertEVPSell4,375$16.41$71,793.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Gregory D PerryCFOSell18,337$17.82$326,765.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Daniel JuniusCEOSell16,667$16.43$273,838.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013John LambertEVPSell4,375$16.45$71,968.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Daniel M JuniusCEOSell16,667$19.21$320,173.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013John LambertEVPSell4,375$19.21$84,043.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013James J O'learyVPSell35,000$19.02$665,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2013Daniel M JuniusCEOSell16,667$17.31$288,505.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013John LambertEVPSell4,375$16.80$73,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013John LambertEVPSell11,250$17.20$193,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013James J O'learyVPSell28,900$18.11$523,379.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2013John LambertEVPSell11,250$15.56$175,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2013James J O'learyVPSell31,100$17.37$540,207.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/8/2012Mark Alan GoldbergDirectorBuy3,000$11.27$33,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ImmunoGen (NASDAQ:IMGN)
DateHeadline
07/25/16 12:30 PMETF’s with exposure to ImmunoGen, Inc. : July 25, 2016 -
07/23/16 08:38 AMImmunoGen Inc (NASDAQ:IMGN) Stock Technicals Hit Extreme Weakness - CML News
07/23/16 08:38 AMImmunoGen, Inc. (NASDAQ:IMGN): Updated Analyst Ratings - Review Fortune
07/22/16 07:33 AMImmunoGen, Inc. (NASDAQ:IMGN): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 04:47 PMRevenue Estimates for Investors: ImmunoGen, Inc. (NASDAQ:IMGN) - News Oracle
07/21/16 04:47 PMImmunoGen Inc. (IMGN) Drops 7.87% on July 19 - Equities.com
07/21/16 02:00 PMImmunoGen, Inc. Announces Conference Call to Discuss Its Fourth Quarter and Fiscal Year 2016 Financial Results - [Business Wire] - ImmunoGen, Inc. , a biotechnology company developing novel antibody-drug conjugate therapeutics, today announced that the Company will host a conference call at 8:00 a.m.
07/20/16 07:37 AMEquity Roundup: Stock Performance Focus on ImmunoGen, Inc. (NASDAQ:IMGN) - Press Telegraph
07/20/16 07:37 AMAnalysts Reviewing Stocks: ImmunoGen, Inc. (NASDAQ:IMGN) , ResMed Inc. (NYSE:RMD) - Street Updates
07/20/16 07:37 AMSummary of Analyst's Study: Merck & Company, Inc. (NYSE:MRK) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates
07/20/16 07:37 AMImmunoGen Inc. (IMGN) Jumps 10.51% on July 18 - Equities.com
07/19/16 10:43 AMParkerVision (PRKR), Carver Bancorp (CARV), Sophiris Bio (SPHS) Lead Big Moving Stocks
07/18/16 03:18 PMWhy ImmunoGen, Inc. Bounded Higher Today -
07/17/16 04:09 PMImmunoGen Inc. (IMGN) Hits New 52-week Low During July 14 Session - Equities.com
07/15/16 03:04 PMAutohome, ImmunoGen Lead Friday’s 52-Week Low Club -
07/15/16 08:14 AMImmunoGen Inc Realized Volatility Hits Extreme Level - CML News
07/15/16 08:14 AMBroker Outlook For ImmunoGen, Inc. (NASDAQ:IMGN) - Fiscal Standard
07/15/16 08:14 AMImmunoGen Inc. (IMGN) Hits New 52-week Low During July 13 Session - Equities.com
07/15/16 08:13 AMHC Stocks Outlines: ImmunoGen, Inc. (NASDAQ:IMGN), Shire PLC (ADR) (NASDAQ:SHPG) - share market updates (press release)
07/14/16 08:07 AMMomentum Stocks: Manhattan Associates, Inc. (MANH), ImmunoGen, Inc. (IMGN), TerraForm Power, Inc. (TERP) - iStreetWire
07/14/16 08:07 AMImmunoGen, Inc. (NASDAQ:IMGN) Stock Rises, Analysts: Hold Rating - Review Fortune
07/13/16 07:31 AMImmunoGen Inc. (IMGN) Drops 7.5% on July 11 - Equities.com
07/12/16 04:52 PMThe Insider Activity Don't Lie: ImmunoGen (NASDAQ:IMGN) - Review Fortune
07/12/16 04:52 PMStock to Focus on: ImmunoGen, Inc. (NASDAQ:IMGN) - News Oracle
07/09/16 04:16 PMHow Many ImmunoGen, Inc. (NASDAQ:IMGN)'s Analysts Are Bearish? - Engelwood Daily
07/08/16 04:48 PMForm DEF 14A MONRO MUFFLER BRAKE INC For: Aug 09
07/08/16 02:40 PMImmunoGen, Inc. Shed 45% of Its Value in June -- Can It Recover? - Moving FORWARD means heading backward first.
07/08/16 07:30 AMImmunoGen Oversold Despite Strong Pipeline - Seeking Alpha
07/07/16 07:29 AMCompany Stock Focus for ImmunoGen, Inc. (NASDAQ:IMGN): Which Way Will Shares Head? - Press Telegraph
07/06/16 04:50 PMImmunogen Inc (NASDAQ:IMGN) Move Down as Institutional Investors' Sentiment Increased - Engelwood Daily
06/30/16 04:52 PMWhy Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead Pharma
06/30/16 07:30 AMDoes ImmunoGen, Inc. Have Any Gas After Today's Huge Decline? - Press Telegraph
06/29/16 04:00 AMThe Montana Tile Worker Who Fought Daughter’s Rare Kidney Cancer -
06/24/16 04:40 PMAnalyst Rating Fluctuations to Observe: Abbott Laboratories (NYSE:ABT) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates
06/24/16 04:40 PMStock in Oversold Area: ImmunoGen, Inc. (NASDAQ:IMGN) - Press Telegraph
06/24/16 07:14 AMImmunoGen, Inc. (NASDAQ:IMGN) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 07:14 AMImmunoGen Inc. (IMGN) Hits New 52-week Low During June 22 Session - Equities.com
06/23/16 07:32 AMImmunoGen Inc. (IMGN) Hits New 52-week Low During June 21 Session - Equities.com
06/22/16 09:17 AMImmunoGen, Inc. (NASDAQ:IMGN) Current Analyst Ratings - Fiscal Standard
06/20/16 04:02 PMIMMUNOGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati -
06/20/16 09:52 AMThis Weeks Broker Views For ImmunoGen, Inc. (NASDAQ:IMGN) - Fiscal Standard
06/17/16 07:20 AMMylan NV (NASDAQ:MYL) & ImmunoGen, Inc. (NASDAQ:IMGN) Healthcare Stocks in Focus - Wall Street 24
06/17/16 07:19 AMImmunoGen Inc. (IMGN) is Trading Higher on Unusual Volume for June 15 - Equities.com
06/17/16 07:19 AMStocks Recommendation Update: AbbVie Inc. (NYSE:ABBV) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates
06/16/16 08:53 AMWhy is ImmunoGen (IMGN) Stock Down Today?
06/15/16 04:40 PMHC Stocks in the Rumor: ImmunoGen, Inc. (NASDAQ:IMGN), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - share market updates (press release)
06/15/16 04:40 PMEarnings Analysis to Watch: Symantec Corporation (NASDAQ:SYMC), ImmunoGen, Inc. (NASDAQ:IMGN) - Beacon Chronicle
06/15/16 04:40 PMWhy ImmunoGen, Inc. Noted a Lower Price Today - Motley Fool
06/15/16 04:40 PMImmunoGen Inc. (IMGN) Drops 29.49% on June 14 - Equities.com
06/15/16 04:40 PMImmunoGen Inc. (IMGN) Plunged To A New Low On Offering News - RTT News

Social

About ImmunoGen

ImmunoGen logoImmunoGen, Inc. (ImmunoGen) is a clinical-stage biotechnology company focused on the development of targeted anticancer therapeutics. The Company's clinical and preclinical product candidates are antibody-drug conjugates (ADCs), which is a type of medicine that uses a monoclonal antibody to deliver a therapeutic agent to targeted cells. The Company has three clinical-stage anticancer compounds: mirvetuximab soravtansine (IMGN853), coltuximab ravtansine, IMGN529, and IMGN779. The Company's partners are Amgen Inc., Bayer HealthCare (a subgroup of Bayer AG), Biotest AG, Eli Lilly and Company (Lilly), Novartis Institutes for BioMedical Research, Inc. (Novartis), the Roche Group, Sanofi and Takeda. The Company's collaborative partner compounds include Kadcyla, Indatuximab ravtansine, Isatuximab, Anetumumab ravtansine, AMG 595, AMG 172, SAR566658, SAR408701, LOP628 and PCA062. All of the Company's compounds are ADCs with the exception of isatuximab, which is a therapeutic antibody.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IMGN
  • CUSIP: 45253H10
Key Metrics:
  • Previous Close: $2.85
  • 50 Day Moving Average: $3.46
  • 200 Day Moving Average: $6.69
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $244.68M
  • Beta: 1.86
  • Current Year EPS Consensus Estimate: $-1.55 EPS
  • Next Year EPS Consensus Estimate: $-1.66 EPS
Additional Links:
ImmunoGen (NASDAQ:IMGN) Chart for Tuesday, July, 26, 2016